
SaaS
Deep Dive Report: TrimRx — GLP-1 Telehealth Weight Loss Subscription Analysis
ProfitSearcher 研究团队
2026-03-23
8 min
Deep Dive Report: TrimRx — GLP-1 Telehealth Weight Loss Subscription Analysis
1. Background
TrimRx (trimrx.com) is a US telehealth platform specializing in GLP-1 medications (Semaglutide, Tirzepatide) for weight loss through a fully digital process — no in-person clinic visits required.
Key Metrics:
- MRR: $277,974 (March 2026)
- MoM Growth: +20%
- Monthly Visits: 2.03M
- US Users: 92.3%
- Launch: ~November 2024 (GLP-1 pivot)
- Pricing: from $179/month (Semaglutide)
2. Product Breakdown
Digital User Journey:
- Online health assessment (BMI, medical history, ~10 min questionnaire)
- Async physician review (licensed doctor, 24-48 hours)
- Personalized Semaglutide/Tirzepatide prescription
- Medication mailed directly home from licensed compounding pharmacy
- Ongoing care team follow-up (dosage adjustments, nutrition guidance)
Differentiation: $179/month vs. $300-500/month at traditional clinics; fully online; compounded Semaglutide at lower cost than brand-name Ozempic.
3. Business Model
Estimated Pricing:
- Semaglutide pl
Want more business insights?
Subscribe to ProfitSearcher for weekly business opportunities and in-depth analysis
Start Free Trial